Company intelligence / Profile preview

Invendo Medical

Cestarostrasse/Kissing/Weinheim, Germanyinfectioncontroltoday.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Invendo Medical developed the world’s first sterile, single-use, robotically assisted HD colonoscopes and GI endoscopes. Their flagship product lines included the invendoscope SC200/SC210 series and E200 system. These devices were designed to reduce infection risk by eliminating reprocessing needs. The second-generation HD colonoscope was expected to receive CE mark and FDA clearance around 2018. The company was acquired by Ambu in October 2017 for up to €225 million ($261 million), integrating its technology into Ambu’s expanding single-use endoscopy portfolio.

Therapeutic areas: Gastroenterology
Modalities: DeviceRobotic-assisted deviceSingle-use endoscopy system
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Invendo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invendo Medical.

Explore the full profile